Wegovy
Every GLP-1 the FDA has approved, and the active ingredient inside each one.
What is Wegovy?
Semaglutide sold as a weekly injection for weight management, approved by the FDA in 2021 and dosed 0.25 to 2.4 mg.
Same molecule as Ozempic, aimed higher. Worth knowing when you shop: a compounded seller advertising “semaglutide” is not selling you Wegovy, and the price gap between the two is the largest in this market.
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Wegovy comes up on this site
On GLP Watchdog, Wegovy comes up in 17 research articles, 89 seller reviews, 7 FDA warning letters and 4 tools. Browse the FDA warning letters.
Research that discusses it
- Wegovy Pill Cost: Every Dose and Every Way to Pay
- Wegovy Pill Side Effects: What the Tablet Label Reports
- Wegovy 7.2 mg: What the Higher Dose Actually Costs
- Compounded Semaglutide vs Ozempic and Wegovy: What Is Actually Different
- Does Medicaid Cover Ozempic and Wegovy? Same Molecule, Different Answers
- Sublingual Semaglutide Drops: What the Evidence Shows
- All 17 articles are on the research page
Drug pages
Tools that use it
Seller reviews that mention it
Other terms under Drugs and brands
Where the evidence lives
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers